Danimer Scientific Announces Successful Expansion of Rinnovo® Demonstration Plant Capacity
22 Fevereiro 2024 - 10:30AM
Business Wire
Newly completed demonstration plant capacity
will accelerate partnership testing
Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the
“Company”), a leading next generation bioplastics company focused
on the development and production of biodegradable materials, today
announced it has successfully completed the expansion of its
Rochester, NY demonstration plant in order to better serve partners
for the testing of Rinnovo® polymers.
Rinnovo® is a type of polyhydroxyalkanoate (“PHA”)
synthesized using a thermocatalytic process, which the Company
believes can be produced at a lower cost than PHA produced via
fermentation processes. The Rinnovo® product platform
boasts unique properties relative to currently marketed PHA
materials, including enhanced barrier properties, increased
elongation and a lower melting temperature. Danimer expects the
capital cost to build out future commercial capacity of
Rinnovo® will be significantly less than commercial
plants using fermentation processes to produce other types of
PHAs.
When operated continuously, the expanded demonstration plant can
produce 20 tonnes annually, which marks an approximate 20x scale up
from the previous production capacity. Key features of the
expansion project include a larger carbonylation reactor,
installation of three additional fractional distillation towers, a
larger polymerization reactor and a polymer drying unit. The
demonstration plant also features enhanced controls and data
collection that will support additional process condition testing
and optimization of the commercial plant design.
Stephen E. Croskrey, Chief Executive Officer of Danimer, said,
“We are thrilled to have the Rinnovo® demonstration
plant expansion completed, allowing us to accelerate our efforts to
gain offtake commitments for this exciting polymer platform.
Further, I would like to commend the entire Danimer team in
Rochester for their efforts to bring the facility on line safely
and within budget.”
For more information on Danimer Scientific, visit
www.DanimerScientific.com.
About Danimer Scientific
Danimer is a pioneer in creating more sustainable, more natural
ways to make plastic products. For more than a decade, its
renewable and sustainable biopolymers have helped create plastic
products that are biodegradable and compostable and return to
nature instead of polluting our lands and waters. Danimer’s
technology can be found in a vast array of plastic end products
that people use every day. Applications for its biopolymers include
additives, aqueous coatings, fibers, films and injection-molded
articles, among others. Danimer holds more than 480 granted patents
and pending patent applications in more than 20 countries for a
range of manufacturing processes and biopolymer formulations. For
more information, visit https://danimerscientific.com.
Forward-Looking Statements
Please note that in this press release we may use words such as
“appears,” “anticipates,” “believes,” “plans,” “expects,”
“intends,” “future,” and similar expressions which constitute
forward-looking statements within the meaning of the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, without limitation, statements
regarding our expectations for full year capital expenditures,
Adjusted EBITDA and cash balances. Forward-looking statements are
made based on our expectations and beliefs concerning future events
impacting the Company and therefore involve a number of risks and
uncertainties. We caution that forward-looking statements are not
guarantees and that actual results could differ materially from
those expressed or implied in the forward-looking statements.
Potential risks and uncertainties that could cause the actual
results of operations or financial condition of the Company to
differ materially from those expressed or implied by
forward-looking statements in this release include, but are not
limited to, the overall level of consumer demand on our products;
general economic conditions and other factors affecting consumer
confidence, preferences, and behavior; disruption and volatility in
the global currency, capital, and credit markets; the financial
strength of the Company's customers; the Company's ability to
implement its business strategy, including, but not limited to, its
ability to expand its production facilities and plants to meet
customer demand for its products and the timing thereof; risks
relating to the uncertainty of the projected financial information
with respect to the Company; the ability of the Company to execute
and integrate acquisitions; changes in governmental regulation,
legislation or public opinion relating to our products; the
Company’s exposure to product liability or product warranty claims
and other loss contingencies; disruptions and other impacts to the
Company’s business as a result of the COVID-19 global pandemic and
government actions and restrictive measures implemented in
response; stability of the Company’s manufacturing facilities and
suppliers, as well as consumer demand for our products, in light of
disease epidemics and health-related concerns such as the COVID-19
global pandemic; the impact on our business, operations and
financial results from the ongoing conflict in Ukraine; the impact
that global climate change trends may have on the Company and its
suppliers and customers; the Company's ability to protect patents,
trademarks and other intellectual property rights; any breaches of,
or interruptions in, our information systems; the ability of our
information technology systems or information security systems to
operate effectively, including as a result of security breaches,
viruses, hackers, malware, natural disasters, vendor business
interruptions or other causes; our ability to properly maintain,
protect, repair or upgrade our information technology systems or
information security systems, or problems with our transitioning to
upgraded or replacement systems; the impact of adverse publicity
about the Company and/or its brands, including without limitation,
through social media or in connection with brand damaging events
and/or public perception; fluctuations in the price, availability
and quality of raw materials and contracted products as well as
foreign currency fluctuations; our ability to utilize potential net
operating loss carryforwards; and changes in tax laws and
liabilities, tariffs, legal, regulatory, political and economic
risks. More information on potential factors that could affect the
Company's financial results is included from time to time in the
Company's public reports filed with the Securities and Exchange
Commission, including the Company's Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.
All forward-looking statements included in this press release are
based upon information available to the Company as of the date of
this press release and speak only as of the date hereof. We assume
no obligation to update any forward-looking statements to reflect
events or circumstances after the date of this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240222655799/en/
Investors Blake Chamblee ir@danimer.com
Media Richard Ivey rivey@danimer.com
Danimer Scientific (NYSE:DNMR)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Danimer Scientific (NYSE:DNMR)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024